PCBs directed by Indian Government to fast track environmental clearance for bulk drug projects in India

As per the notification released by the ministry of environment and forest office, the Central Government has decided to fast track the proposals to set up the bulk drug companies and permission of production of bulk drugs in the country and accordingly has asked central pollution control board and all the state pollution control boards to speed up environmental clearances to enable firms to start manufacturing the bulk drugs in the country to meet the growing demand.

As already the imports of APIs and other key starting materials (KSMs) have completely stalled from China the inventory stocks of APIs and other KSMs required for manufacturing medicines stocked by the pharmaceutical manufacturing firms have started fast receding, the central government is mulling various ways and means to ensure adequate bulk drugs and APIs are supplied to the pharmaceutical industries so that there is no dearth of shortage of medicines.
A senior officer from Telangana Pollution Control Board said, “With the novel coronavirus spreading at a faster pace underneath, the central government has decided to take early preparatory steps to ensure adequate bulk drug supplies are available to the pharma firms in the coming days to meet the growing domestic demand. Keeping this in mind the central government has released a notification directing all the pollution control boards to fast tract environmental clearances for all kinds of bulk drug manufacturing proposals within the country,”

“This is a welcome move by the central government. In fact this indication should have been given two years ago by the government, however though late it has come well in time. It may take some time for the bulk drug firms to set up facilities, but overall this decision by the central government is definitely going to boost the bulk drug sector in the coming days,” said P V Appaji, former director general of Pharmexcil.

A ministry official memorandum had also said that the issue has been cleared and will be implemented with immediate effect.

  • Related Posts

    • Health
    • February 10, 2024
    • 236 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Millets reigned Supreme in International Symposium on Gut Health

    New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt